我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

PCI和CABG治疗单纯左主干病变效果进展

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2018年第3期
页码:
364-367
栏目:
综述
出版日期:
2018-03-25

文章信息/Info

Title:
Treatment effects of percutaneous coronary intervention and coronary artery bypass graft surgery for left main coronary artery disease
作者:
覃雄海 综述; 蒋树林; 康 凯 审校
（哈尔滨医科大学附属第二医院心脏外科，黑龙江 哈尔滨 150086）
Author(s):
QIN Xiong-hai;  JIANG Shu-lin;  KANG Kai
(Department of Cardiovascular Surgery, Second Affiliated Hospital, Harbin Medical University, Harbin 150086, Heilongjiang, China)
关键词:
经皮冠状动脉介入治疗; 冠状动脉旁路移植术; 左主干病变; 血运重建
Keywords:
percutaneous coronary intervention;  coronary artery bypass graft surgery;  left main coronary artery disease;  revascularization
分类号:
R541.4
DOI:
-
文献标识码:
A
摘要:
随着基础医学、医疗设备、高新技术的进展和循证医学的广泛开展，血运重建技术已经取得了快速的进展。左主干病变可通过内科和外科手段实现心肌血运重建，缓解症状，改善预后和延长寿命。目前血运重建措施有经皮冠状动脉介入治疗(PCI)和冠状动脉旁路移植术(CABG)。但是对于更适当的治疗措施尚无定论。故本文就PCI和CABG在左主干病变患者的治疗效果做一综述。
Abstract:
With the progress of basic medicine, medical equipment, high and new technology and evidence-based medicine, the technology of revascularization has developed rapidly. For left main coronary artery disease, medication and surgery can achieve myocardial revascularization, relieve symptoms, improve prognosis and prolong life. At present, the measures adopted to achieve revascularization are percutaneous coronary intervention and coronary artery bypass graft surgery. In this review, our investigation describes current treatment strategies of percutaneous coronary intervention and coronary artery bypass graft surgery for left main coronary artery disease.

参考文献/References

[1]GBD 2013 Mortality and Causes of Death Collaborators.Global,regional,and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013:a systematic analysis for the Global Burden of Disease Study 2013[J].Lancet,2015,385(9963):117-171.

[2]Hoffman SN,Ten Brook JA, Wolf MP,et al.A meta-analysis of randomized controlled trials comparing coronary-artery bypass graft with percutaneous transluminal coronary angioplasty:one-to eight-year outcomes[J].Am Coll Cardiol,2003,41(8):1293-1304.

[3]Hannan EL,Racz MJ,Walford G,et al Long-term outcomes of coronary-artery bypass grafting versus stent implantation[J].N Engl J Med,2005,353(7):2174-2183.

[4]Holmes DR.Revascularization in stable coronary artery disease:a combined perspective from an interventional cardiologist and a cardiac surgeon[J].Eur heart J,2016,37(24):1873-1882.

[5]Sabiston DC,Jr.Direct surgical management of congenital and acquired lesions of the coronary circulation[J].Prog Cardiovasc Dis,1963,6:299-316.

[6]Athappan G,Patvardhan E,Tuzcu ME,et al.Left main coronary artery stenosis:a meta-analysis of drug-eluting stents versus coronary artery bypass grafting[J].JACC Cardiovasc interv,2013,6(12):1219-1230.

[7]Cohen DJ,Osnabrugge RL,Magnuson EA,et al.Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease:final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery(SYNTAX)trial[J].Circulation,2014,130(14):1146-1157.

[8]WRITING COMMITTEE MEMBERS,Yancy CW,Jessup M,et al.2013 ACCF/AHA Guideline for the management of Heart Failure:a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines[J].Circulation,2013,128(16):e240-e327.

[9]Windecker S,Kolh P,Alfonso F,et.al.2014 ESC /EACTS Guidelines on myocardial revascularization[J].Kardiol Pol,2014,72(12):1253-1379.

[10]Kolh P,Windecker S,Alfonso F,et al.2014 ESC /EACTS Guidelines on myocardial revascularization:the Task Force on Myocardial Revascularization of the European Society of Cardiology(ESC)and the European Association for Cardio-Thoracic Surgery(EACTS).Developed with the specialcontribution of the European Association of Percutaneous Cardiovascular Interventions(EAPCI)[J].Eur J Cardiothorac Surg,2014,46(4):517-592.

[11]Athappan G,Patvardhan E,Tuzcu ME,et al.Left main coronary artery stenosis: a meta-analysis of drug-eluting stents versus coronary artery bypass grafting[J].JACC Cardiovasc Interv,2013, 6(12):1219-1230.

[12]Ahn JM,Roh JH,Kim YH,et al.Randomized trial of stents versus bypass surgery for left main coronary artery disease:5-year outcomes of the PRECOMBAT study[J].J Am Coll Cardiol,2015,65(20):2198-2206.

[13]Morice MC,Serruys PW,Kappetein AP,et al.Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial［J］. Circulation, 2014, 129(23):2388-2394.

[14]Milojevic M,Head SJ,Parasca CA,et al.Causes of Death Following PCI Versus CABG in Complex CAD:5-Year Follow-Up of SYNTAX[J].J Am Coll Cardiol,2016,67(1):42-55.

[15]Athappan G,Patvardhan E,Tuzcu ME,et al.Left main coronary artery stenosis: a meta-analysis of drugeluting stents versus coronary artery bypass grafting[J].J Am Coll Cardiol Intv,2013,6(12):1219-1230.

[16]Alam M,Virani SS,Shahzad SA,et al.Comparison by meta-analysis of percutaneous coronary intervention versus coronary artery bypass grafting in patients with a mean age of ≥70 years[J].Am J Cardiol,2013,112(5):615-622.

[17]Chang M,Ahn JM,Lee CW,et al.Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease[J].J Am Coll Cardiol,2016,68(1):29-36.

[18]Chang M,Lee CW,Ahn JM,et al.Coronary Artery Bypass Grafting Versus Drug-Eluting Stents Implantation for Previous Myocardial Infarction[J].Am J Cardiol,2016,118(1):17-22.

[19]张 扬,谭 强,王庆胜,等.老年患者无保护左主干病变介入治疗临床分析[J].中华实用诊断与治疗杂志,2016,30(3):276-278.

[20]Harskamp RE,Williams JB,Halkos ME,et al.Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease[J].J Thorac Cardiovasc Surg,2014,148(5):1837-1842.

[21]Stone GW,Sabik JF,Serruys PW,et al.Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease[J].N Engl J Med,2016,375(23):2223.

[22]张 雯,舒 欣.药物洗脱支架与冠脉旁路手术治疗冠状动脉左主干病变的临床研究[J].中国临床研究,2016,29(1):68-71.

[23]Athappan G,Chacko P,Patvardhan E,et al.Late stroke: comparison of percutaneous coronary intervention versus coronary artery bypass grafting in patients with multivessel disease and unprotected left main disease: a meta-analysis and review of literature[J].Stroke, 2014, 45(1):185-193.

[24]高彦娜,孙同文,张晓娟,等. 冠心病药物、介入治疗和冠脉搭桥术的长期疗效对比分析［J］. 河南医学研究, 2016, 25(4):619-622.

[25]Loponen P, Luther M, Korpilahti K, et al. HRQOL after coronary artery bypass grafting and percutaneous coronary intervention for stable angina［J］. Scand Cardiovasc J, 2009, 43(2):94-99.

[26]Weintraub WS, Grau-Sepulveda MV,Weiss JM, et al. Comparative effectiveness of revascularization strategies［J］. N Engl J Med, 2012, 366(16):1467-1476.

[27]Kumasawa J,Kurita N,Fukuhara S. Comparative effectiveness of multivessel coronary artery bypass graft surgery and multivessel percutaneous coronary intervention[J].Ann Intern Med,2013,159(6):435.

[28]Yazdani-Bakhsh R,Javanbakht M,Sadeghi M,et al.Comparison of health-related quality of life after percutaneous coronary intervention and coronary artery bypass surgery[J].ARYA Atheroscler,2016,12(3):124-131.

备注/Memo

备注/Memo:
收稿日期：2016-12-09.通讯作者：蒋树林，主任医师，主要从事心血管疾病外科治疗研究 Email:sljiang36@163.com 作者简介：覃雄海，硕士生 Email：qxh9069@163.com
更新日期/Last Update: 1900-01-01